LAKE FOREST, Calif.--(BUSINESS WIRE)--Sept. 10, 2004--I-Flow Corporation (Nasdaq:IFLO) announced today that it will address institutional shareholders at the Roth Capital Partners New York Conference on Monday, September 13, 2004, at 9:00 a.m. EDT.

The conference will take place from September 13 through 15, at the St. Regis Hotel in New York City. Donald M. Earhart, I-Flow's Chairman, President, and Chief Executive Officer, will make a presentation describing the Company's growth strategies and market opportunities for its Regional Anesthesia business.

I-Flow Corporation is an emerging leader in post-surgical pain relief. The Company's ON-Q(R) PainBuster(R) Post-Op Pain Relief System provides targeted pain relief after surgery only where the body needs it, delivering a non-narcotic, pain-numbing medication directly to an incision site for up to five days. The anesthetic is administered through a specially designed catheter inserted by a surgeon during surgery. ON-Q PainBuster is cleared for use by the U.S. Food & Drug Administration (FDA), and is now labeled to significantly reduce pain and narcotics intake after surgery.

You can access the live 30-minute webcast and slide presentation, after registration, from the Investors link or the Investors' Event Calendar link at www.IFLO.com. The webcast, which requires the Windows Media Player, will be immediately available for replay for sixty days at these same internet addresses.

About I-Flow

I-Flow Corporation (www.IFLO.com) designs, develops and markets technically advanced, low-cost drug delivery systems and services that are redefining the standard of care by providing life-enhancing, cost-effective solutions for pain relief.

Certain disclosures made by the Company in this press release and in other reports and statements released by the Company are and will be forward-looking in nature, such as comments that express the Company's opinions about trends and factors which may impact future operating results. Disclosures that use words such as the Company "believes," "anticipates," or "expects" or use similar expressions are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, which could cause actual results to differ from those expected, and readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to republish revised forward-looking statements to reflect the occurrence of unanticipated events. Readers are also urged to carefully review and consider the various disclosures made by the Company in this report which seek to advise interested parties of the risks and other factors that affect the Company's business, as well as in the Company's periodic reports on Forms 10-K, 10-Q, and 8-K filed with the Securities and Exchange Commission. The risks affecting the Company's business include reliance on the success of the home health care industry, the reimbursement system currently in place and future changes to that system, competition in the industry, economic conditions in foreign countries, currency exchange rates, technological changes, product availability and the Company's efforts to rapidly build a substantial direct sales force. Any such forward-looking statements, whether made in this report or elsewhere, should be considered in context with the various disclosures made by the Company about its business.

    CONTACT: I-Flow Corporation
             James R. Talevich, 949-206-2700
             www.IFLO.com
             or
             Berkman Associates
             John Hicks, 310-277-5162 (Investors)
             info@BerkmanAssociates.com

    SOURCE: I-Flow Corporation